Skip to main content

Table 3 Sequences of shRNA against TTK for transfection

From: TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer

Name

Sequence

shCtrl (scrambled sequence)

5′-CCTAAGGTTAAGTCGCCCTCG-3′

shTTK-1

5′-GATAAGATCATCCGACTTTAT-3′

shTTK-2

5′-GCACAATTTGAACTGTCACAA-3′